03 May 2018 : Laboratory Research
Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC)
DOI: 10.12659/MSM.907514
Med Sci Monit 2018; 24: LBR2735-2743
HTML version available soon